28 Apr 2017 | Livemint.com

BSE
NSE
Last Updated: Mar 31, 03:46 PM
Parenteral Drugs (India) Ltd.

BSE

  • 27.10 -0.40 (-1.45%)
  • Vol: 8390
  • BSE Code: 524689
  • PREV. CLOSE
    27.50
  • OPEN PRICE
    28.20
  • BID PRICE (QTY.)
    0.00(0)
  • OFFER PRICE (QTY.)
    27.30(1000)

NSE

  • 27.00 0.00 (0%)
  • Vol: 18628
  • NSE Code: PDPL
  • PREV. CLOSE
    27.00
  • OPEN PRICE
    28.45
  • BID PRICE (QTY.)
    0.00(0)
  • OFFER PRICE (QTY.)
    27.00(1301)

Parenteral Drugs (India) Ltd. Board Meetings

From date
To date
Source Date Board Meeting Date Details
07-Feb-201713-Feb-2017 Quarterly Results & Parenteral Drugs India Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on February 13, 2017, inter alia, to consider : 1. The Unaudited (Provisional) Financial Results of the Company for the third quarter of the financial year 2016- 17 ended on December 31, 2016. 2. The sale of Kasrawad and Baddi undertakings of the Company on slump sale basis to the wholly owned subsidiary of the company, subject to approval of the secured lenders and shareholders.
16-Nov-201614-Nov-2016
18-Oct-201621-Oct-2016 Parenteral Drugs India Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on October 21, 2016, inter-alia, to consider erosion of net worth of the company and report to the Board of Industrial and Financial Reconstruction pursuant to the provisions of Section 23 of the Sick Industrial Companies (Special Provisions) Act, 1985 and other items as per agenda of the meeting.
12-Aug-201612-Aug-2016 Quarterly Results
26-May-201630-May-2016 Audited Results
10-Feb-201613-Feb-2016 Quarterly Results
28-Dec-201530-Dec-2015Parenteral Drugs India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on December 30, 2015, inter alia, to consider disinvestment of shares held by the Company in its non-operational Subsidiary Companies, declaration of defunct of non-working Subsidiary companies and other items as per agenda of the meeting. As per the provisions of regulation 9 and Schedule B of the SEBI (Prohibition of Insider Trading) Regulations, 2015, in respect of Company’s Code of Conduct to regulate, monitor and report trading by insiders for Prevention of Insider Trading in the Equity shares and for the aforesaid purpose the "Trading Window" of the Company shall remain closed from the date of intimation i.e. December 26, 2015 to January 01, 2016 and will open on January 02, 2016 for insiders accordingly.
03-Nov-201509-Nov-2015 Quarterly Results
28-Sep-201530-Sep-2015Parenteral Drugs India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on September 30, 2015, inter alia, to consider the allotment of 0% Non-cumulative, Non-convertible, Redeemable Preference Shares of the Company and other items as per agenda of the meeting. Also, according to Schedule B the SCBI (Prohibition of Insider Trading) Regulations, 2015, in respect of Company's Code of Conduct to regulate, monitor and report trading by insiders for Prevention of Insider Trading in the Equity shares, the "Trading Window" of the Company shall remain closed from September 22, 2015 to October 02, 2015 and will open on October 03, 2015 for insiders accordingly.
23-Sep-201530-Sep-2015 The Board of Directors of the Company will be held on September 30, 2015, inter alia, to consider the allotment of 0% Non-cumulative, Non-convertible, Redeemable Preference Shares of the Company and other items as per agenda of the meeting.
13-Jul-201518-Jul-2015 Quarterly Results
29-May-201530-May-2015 Audited Results
27-Mar-201530-Mar-2015 The Board of Directors of the Company will be held on March 30, 2015, to consider items as per agenda of the meeting.
06-Feb-201510-Feb-2015 Quarterly Results
12-Nov-201414-Nov-2014 Quarterly Results
07-Aug-201414-Aug-2014 Quarterly Results